Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia, Myeloid, Acute 12Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Lymphoma 3Leukemia, Promyelocytic, Acute 3Congenital Abnormalities 3Leukemia, Biphenotypic, Acute 2Neutropenia 1Lymphatic Diseases 1Leukemia, Myeloid 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Breast Neoplasms 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × Daunorubicin × Clear all
NCT00004207 2014-06-24

Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡